Edition:
United States

DarioHealth Corp (DRIO.OQ)

DRIO.OQ on NASDAQ Stock Exchange Capital Market

0.79USD
22 Jan 2019
Change (% chg)

-- (--)
Prev Close
$0.79
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
22,496
52-wk High
$2.14
52-wk Low
$0.66

Latest Key Developments (Source: Significant Developments)

DarioHealth Corp Files For Offering Of Up To 6.1 Mln Shares Of Co's Common Stock By Selling Stockholders
Tuesday, 15 Jan 2019 04:09pm EST 

Jan 15 (Reuters) - DarioHealth Corp ::DARIOHEALTH CORP FILES FOR OFFERING OF UP TO 6.1 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING.  Full Article

Dariohealth Reports Third Quarter 2018 Results
Tuesday, 13 Nov 2018 06:30am EST 

Nov 13 (Reuters) - DarioHealth Corp ::DARIOHEALTH REPORTS THIRD QUARTER 2018 RESULTS.Q3 REVENUE ROSE 37 PERCENT TO $1.88 MILLION.QUARTERLY LOSS PER SHARE $0.17.  Full Article

DarioHealth Appoints Yoav Shaked As Chairman Of Board
Monday, 9 Jul 2018 08:00am EDT 

July 9 (Reuters) - DarioHealth Corp ::DARIOHEALTH APPOINTS HEALTHCARE TECHNOLOGY ENTREPRENEUR AND VENTURE CAPITAL PARTNER YOAV SHAKED AS CHAIRMAN OF THE BOARD.DARIOHEALTH CORP - CEO EREZ RAPHAEL SHALL CONTINUE SERVING ON BOARD.  Full Article

DarioHealth Yoav Shaked Appointed Chairman Of Board
Friday, 6 Jul 2018 04:30pm EDT 

July 6 (Reuters) - DarioHealth Corp ::DARIOHEALTH CORP SAYS ON JULY 5, YOAV SHAKED WAS APPOINTED AS A DIRECTOR AND CHAIRMAN OF BOARD OF DIRECTORS - SEC FILING.DARIOHEALTH CORP - EREZ RAPHAEL, CO'S CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF BOARD, NOTIFIED BOARD OF HIS RESIGNATION AS CHAIRMAN OF BOARD.  Full Article

DarioHealth Corp Reports Quarterly Loss Per Share Of $0.20
Tuesday, 15 May 2018 08:00am EDT 

May 15 (Reuters) - DarioHealth Corp ::DARIOHEALTH REPORTS FIRST QUARTER 2018 RESULTS.Q1 REVENUE ROSE 74 PERCENT TO $1.76 MILLION.QUARTERLY LOSS PER SHARE $0.20.  Full Article

Dariohealth - ‍ Received Therapeutic Goods Administration Mark For Its Lightning-Enabled Version Of Dario Blood Glucose Monitoring System
Monday, 18 Dec 2017 08:00am EST 

Dec 18 (Reuters) - Dariohealth Corp ::DARIOHEALTH - ‍ RECEIVED THERAPEUTIC GOODS ADMINISTRATION MARK FOR ITS LIGHTNING-ENABLED VERSION OF DARIO BLOOD GLUCOSE MONITORING SYSTEM IN AUSTRALIA​.DARIOHEALTH - ‍ USERS IN U.K. WILL BE ABLE TO PURCHASE LIGHTNING -ENABLED DARIO DEVICE AT END OF DEC, SALES OF DEVICE TO BEGIN IN AUSTRALIA BY JAN 2018​.  Full Article

Dariohealth Corp Q3 revenue $1.375 million
Tuesday, 14 Nov 2017 07:00am EST 

Nov 14 (Reuters) - Dariohealth Corp :Dariohealth reports third quarter 2017 results.Q3 revenue rose 89 percent to $1.375 million.Qtrly basic and diluted loss per share $0.30‍​.  Full Article

DarioHealth says selling stockholders may offer from time to time up to 2.9 mln shares of common stock‍​
Thursday, 19 Oct 2017 05:27pm EDT 

Oct 19 (Reuters) - Dariohealth Corp :DarioHealth Corp - selling stockholders may offer from time to time up to 2.9 million shares of co's common stock - SEC filing‍​.  Full Article